本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

20.07
-0.0800-0.40%
盤後20.180.1100+0.55%18:14 EST
成交量:162.72萬
成交額:3,275.07萬
市值:25.66億
市盈率:116.41
高:20.39
開:20.21
低:19.75
收:20.15
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.76
換手率:2.08%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:6.93
市盈率(LYR):116.41

資料載入中...

2023/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

重要事件披露

Form 8-K - Current report
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

SEC問詢函

Form CORRESP - Correspondence
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/01

重要事件披露

Form 8-K - Current report
2023/11/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities